Join colleagues – clinicians and researchers from over 25 countries – for the seventh edition of this event which has come to be recognized as THE major international conference that covers specific targeted therapies for hereditary cancer. It is an accredited continuing educational activity for physicians, nurses and genetic counselors.
BRCA: From the Personal to the Population represents a unique opportunity to look at all aspects of breast and ovarian cancer, and in particular the susceptibility genes, BRCA1 and BRCA2, which are responsible for a considerable fraction of early-onset breast cancer.
Topics covered will include the origins, diagnosis and outcome of BRCA-related cancer, prevention and treatment of HBOC, population testing and new challenges in genetic counseling, to name just a few.
We are pleased to once again issue a Call for Abstracts for oral and poster presentations. Interested participants are invited to submit abstracts on topics related to hereditary breast and ovarian cancer. Submissions are welcome from all disciplines. Click here to go to the Call for Abstracts page.
Deadline for Oral Abstract Submissions: December 8, 2017
Deadline for Poster Abstract Submissions: January 19, 2018
The tradition of an all-day Public Session for patients, families and interested members of the public will continue as part of our commitment to educate and inform the wider population about BRCA 1 and 2. Click here.